US 8609706
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
granted A61KA61K31/42A61K31/422
Quick answer
US patent 8609706 (Compounds and methods for inhibiting the interaction of BCL proteins with binding partners) held by Infinity Discovery, Inc. expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Infinity Discovery, Inc.
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K31/427, A61K31/4439